These components include (i) tumor‐infiltrating T cells with the objective of boosting their activation,123 (ii) cancer‐associated fibroblasts which have been shown to be pro‐tumorigenic,124 (iii) TAMs which are also known to promote tumor growth and progression,125 (v) immunosuppressive cytokines such as TGFβ,126 and (vi) Treg cells, which are typically associated with poor prognosis.127. The gene discussed is TGFB1; the disease is neoplasm.